Literature DB >> 16133519

Atypical mycobacterial cervical lymphadenitis with extensive local spread: a surgical disease.

M Hogan1, D Price, K Burrage, C Pushpanathan.   

Abstract

Atypical (nontuberculous) mycobacterium is an uncommon cause of cervical lymphadenitis in immunocompetent children. Rarely, this disease progresses to locoregional destruction of the deep structures of the neck including salivary glands. Recent reports suggest medical monotherapy as an effective treatment of this disease. We report three cases of children who experienced progression to locoregional disease while on appropriate antibiotics. We suggest that the patient population to benefit from medical monotherapy has yet to be adequately defined. In our experience, surgical therapy is the only effective treatment for locoregional disease.

Entities:  

Mesh:

Year:  2005        PMID: 16133519     DOI: 10.1007/s00383-005-1491-9

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  12 in total

1.  Management of nontuberculous mycobacterial cervical adenitis.

Authors:  J R Starke
Journal:  Pediatr Infect Dis J       Date:  2000-07       Impact factor: 2.129

2.  Treatment options for nontuberculous mycobacterial adenitis in children.

Authors:  Ann M Loeffler
Journal:  Pediatr Infect Dis J       Date:  2004-10       Impact factor: 2.129

3.  Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin.

Authors:  C Berger; G E Pfyffer; D Nadal
Journal:  J Pediatr       Date:  1996-03       Impact factor: 4.406

4.  Atypical mycobacterial infection of the parotid gland.

Authors:  P N Rieu; P van den Broek; M Pruszczynski; P C de Wilde; C Festen
Journal:  J Pediatr Surg       Date:  1990-05       Impact factor: 2.545

5.  Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol.

Authors:  P A Green; C F von Reyn; R P Smith
Journal:  Pediatr Infect Dis J       Date:  1993-07       Impact factor: 2.129

6.  Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children.

Authors:  M H Tessier; J C Amoric; F Méchinaud; D Dubesset; P Litoux; J F Stalder
Journal:  Lancet       Date:  1994 Dec 24-31       Impact factor: 79.321

7.  Atypical mycobacterial disease in children: a personal series.

Authors:  I Mushtaq; H C O Martin
Journal:  Pediatr Surg Int       Date:  2002-10-24       Impact factor: 1.827

Review 8.  Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy.

Authors:  R Hazra; C D Robson; A R Perez-Atayde; R N Husson
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

9.  Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections.

Authors:  J A Lindeboom; J de Lange; H P van den Akker
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-01

10.  Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases.

Authors:  U B Schaad; T P Votteler; G H McCracken; J D Nelson
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

View more
  4 in total

1.  Atypical mycobacteriosis in children: a diagnostic and therapeutic challenge.

Authors:  C M C Deichmueller; K Emmanouil; H-J Welkoborsky
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-03       Impact factor: 2.503

2.  [Bacterial sialadenitis].

Authors:  H Maier; M Tisch
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

3.  Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children.

Authors:  Luciana Breda; Giuseppina de Michele; Manuela Nozzi; Sara De Sanctis; Daniele Di Marzio; Francesco Chiarelli
Journal:  Rheumatol Int       Date:  2009-01-21       Impact factor: 2.631

Review 4.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.